Live Market Updates
Latest Financial News
News Feed
1 articles
Personalized
Live Market Updates
Latest Financial News
positive
7 days agoOpenAI Invests in Biosecurity Startup Valthos to Strengthen AI-Driven Biodefense
OpenAI has joined Founders Fund and Lux Capital in a $30 million seed round for Valthos, a biosecurity startup using artificial intelligence to detect and prevent engineered biological threats. The company’s system applies deep genomic modeling to identify anomalies that could indicate lab-created pathogens or bioengineering misuse. Analysts view this move as OpenAI’s first major investment into global biodefense and AI safety, aligning with its broader focus on responsible and safe artificial intelligence applications.
Explore:Mutual Fund Themes
positive
7 days agoOpenAI Invests in Biosecurity Startup Valthos to Strengthen AI-Driven Biodefense
OpenAI has joined Founders Fund and Lux Capital in a $30 million seed round for Valthos, a biosecurity startup using artificial intelligence to detect and prevent engineered biological threats. The company’s system applies deep genomic modeling to identify anomalies that could indicate lab-created pathogens or bioengineering misuse. Analysts view this move as OpenAI’s first major investment into global biodefense and AI safety, aligning with its broader focus on responsible and safe artificial intelligence applications.
Explore:Mutual Fund Themes
positive
OpenAI Invests in Biosecurity Startup Valthos to Strengthen AI-Driven Biodefense
7 days ago
1 min read
74 words
OpenAI invests $30 million in Valthos, an AI-based biosecurity firm combating engineered biothreats using genomic intelligence and deep-learning surveillance technology.
OpenAI has joined Founders Fund and Lux Capital in a $30 million seed round for Valthos, a biosecurity startup using artificial intelligence to detect and prevent engineered biological threats. The company’s system applies deep genomic modeling to identify anomalies that could indicate lab-created pathogens or bioengineering misuse. Analysts view this move as OpenAI’s first major investment into global biodefense and AI safety, aligning with its broader focus on responsible and safe artificial intelligence applications.
OpenAI has joined Founders Fund and Lux Capital in a $30 million seed round for Valthos, a biosecurity startup using artificial intelligence to detect and prevent engineered biological threats. The company’s system applies deep genomic modeling to identify anomalies that could indicate lab-created pathogens or bioengineering misuse. Analysts view this move as OpenAI’s first major investment into global biodefense and AI safety, aligning with its broader focus on responsible and safe artificial intelligence applications.
Tags:
OpenAI
Valthos
OpenAI
Valthos
biosecurity
AI
startups
Oct 24, 2025 • 22:30 IST